SaMD Development and the Use of AI Tooling

Randy Horton
Randy Horton
Nov 2025 Webinar Banner Post

While much attention has been given to AI-enabled medical devices, this session explores something equally important: How AI is embedded within the tools developers use to build those devices.

AI tooling is changing how medical device software is developed. But when these tools are used in regulated environments, safety, validation, and compliance become critical, and a new set of related (and interesting) challenges arises.

Orthogonal and SoftComply co-hosted a focused conversation about using AI tools responsibly in the development of SaMD and other medical device software.

Our experts explained how FDA and MDR guidance apply to AI-powered development tools, what risk and validation challenges they introduce, and how teams can adopt them safely without slowing innovation.

Marion Lepmets

CEO & Co-Founder, SoftComply

Marion Lepmets

Matteo Gubellini

Co-Founder & Chief Regulatory Officer, SoftComply

Matteo Gubellini

Bernhard Kappe

Founder & CEO, Orthogonal

Bernhard Kappe

Randy Horton, VP of Solutions and Partnerships, Orthogonal

Chief Solutions Officer, Orthogonal

Randy Horton

Related Posts

Talk

SaMD, Digital Ecosystems and the New Rules for Cybersecurity

Talk

Medical Device Manufacturers as Providers: A New and Emerging MedTech Model

Talk

Leveraging Automation to Deliver High-Quality MedTech Software

Talk

The Playbook for Running a Multi-Partner Engineering Organization